FDA sued over lethal injection drug import; Teva gets FDA warning;

> The FDA is being sued on behalf of death-row prisoners; lawyers are demanding that a Federal District Court prohibit importation and use of sodium thiopental. Article 

> Teva has received an FDA warning letter following the September inspection of its oral solid dosage manufacturing plant in Jerusalem. Story

> "Questionable" manufacturing and marketing practices have led to the third big financial hit GSK has taken since mid-2010, a fourth-quarter legal charge of $3.5 billion. Article

> Thanks to tip-offs by manufacturers, the FDA was able to avert 38 drug shortages last year by helping to find raw material suppliers, alternative production sites and foreign manufacturers. News

> Improved manufacturing efficiency from its Project Fuel optimization initiatives was more than offset by lower net sales and higher expenses for Hospira, resulting in a 37 percent decline in fourth-quarter profit. Report

> U.K. CMO NextPharma is adding prefilled syringe capabilities at its facility in Belgium. Item

> Lack of senior leadership and poor visibility of the supply chain to execs are the main barriers to strategy implementation. Story

> NextPharma has named Brigitte Genard quality director at its sterile contract development and manufacturing plant in Belgium. NextPharma release